All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q2 report for GLAXOSMITHKLINE LLC on July 5, 2026, reporting $50,000 in lobbying income.
Lobbying for GLAXOSMITHKLINE LLC · Pharmaceutical Company.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 5, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
2
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
-
SOPHIE KHANAHMADIPreviously held: Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
Government bodies contacted
4
Lobbying activity
2
General health care coverage issues. Healthcare reform.
Reimbursement issues for prescription drugs. Drug pricing reform. Vaccine Access. Food and Drug Administration legislative and regulatory issues.